|
Olympus reviewed the following literature titled "outcomes of endoscopic sub-mucosal dissection in laterally spreading colorectal polyps: a tertiary care centre experience from india".Literature summary background: endoscopic sub-mucosal dissection (esd) is an established endoscopic modality for the management of colorectal polyps.However, there are no studies regarding the outcomes of esd from india.In this study, we aimed at evaluating the outcomes of esd in patients with adenomatous polyps in the colon and rectum.Methods: data of consecutive patients who underwent esd for colorectal polyps from 2018 to 2021 were analyzed, retrospectively.The primary outcome of the study was the technical success of esd.The secondary outcomes included the rate of histologically complete resection (r0), adverse events and recurrence.Results: seventy patients (63.5 years, 60% males) underwent esd for polyps in colon and rectum.A majority were located in rectum (80%) and sigmoid colon (15.7%).Narrow band classification of the polyps was japanese narrow band imaging expert team (jnet)-2a in 50 (71.4%) and jnet-2b in 13 (18.6%) patients.Esd was technically successful in 64 (91.4%) patients using conventional technique (72.8%) and pocket or tunnelling technique (18.6%).There were no major adverse events.Histologically ro was achieved in 58 (82.8%) patients and deep sub-mucosal invasion was noted in 12 patients.At a median follow-up of 19 (interquartile range [iqr] 15¿27) months, recurrence was noticed in four (5.7%) patients all of which could be managed endoscopically.Conclusion: esd, performed at a tertiary care centre in india, yields high rates of technical success and histologically r0, with a relatively low incidence of adverse events and recurrences.Adverse events: adverse events were defined according to the american society of gastrointestinal endoscopy (asge) lexicon for adverse events.There were nine adverse events categorized as mild in four (5.7%) and moderate in five (7.1%) patients according to lexicon for adverse events by asge.Mild adverse events included delayed bleeding not requiring an endoscopic intervention in one and perforation successfully closed intra-operatively in three patients.Moderate adverse events included delayed bleeding requiring an endoscopy in three and perforation requiring prolonged hospital stay in two patients.There were no major adverse events.Type of adverse events/number of patients.Delayed bleeding (mild - 1 patient, moderate - 3 patients).Perforation (mild - 3 patients, moderate - 2 patients).
|
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the reported event was likely an accident, or a complication associated with a surgical procedure while using the subject device.There was no complaint reported on the subject device and no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|